Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

COMPLETED NA

Study of Low Level Laser Therapy to Treat Low Back Pain

NCT01835756 · View on ClinicalTrials.gov ↗

Study Summary

The purpose of this study is to determine whether the Erchonia® ML Scanner (MLS) is effective in the treatment of acute minor episodic chronic low back pain of musculoskeletal origin.

Conditions Studied

Interventions

  • DEVICE Placebo Laser
  • DEVICE Erchonia MLS

Study Locations (2)

Arizona

  • South Mountain Chiropractic Center — Chandler
  • Mark B. Burdorf DC — Scottsdale

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2012-09
Est. Completion 2014-09
Phase NA

Sponsor

Erchonia Corporation

10 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01835756

The ClinicalTrials.gov registry entry for NCT01835756 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Erchonia Corporation, which has 10 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 1 condition, with Low Back Pain appearing as the primary indexed condition, and to 2 interventions — of which Placebo Laser is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT01835756 reports 2 study locations spanning 1 distinct geographic area — top geographies include Arizona. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT01835756 about?

NCT01835756 is a clinical study titled "Study of Low Level Laser Therapy to Treat Low Back Pain". The purpose of this study is to determine whether the Erchonia® ML Scanner (MLS) is effective in the treatment of acute minor episodic chronic low back pain of musculoskeletal origin.

What is the current status of trial NCT01835756?

This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2012-09. Estimated completion is 2014-09.

What conditions does trial NCT01835756 study?

This clinical trial studies the following conditions: Low Back Pain. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT01835756?

The interventions under investigation include: Placebo Laser (DEVICE), Erchonia MLS (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT01835756?

This trial is sponsored by Erchonia Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT01835756 being conducted?

This trial has 2 study locations across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial